These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit. Agren LC, Ekman L, Löwenadler B, Lycke NY. J Immunol; 1997 Apr 15; 158(8):3936-46. PubMed ID: 9103464 [Abstract] [Full Text] [Related]
23. Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB/c mice. Zhao W, Wu W, Xu X. Vaccine; 2007 Nov 01; 25(44):7664-73. PubMed ID: 17913305 [Abstract] [Full Text] [Related]
27. Mucosal vaccines based on the use of cholera toxin B subunit as immunogen and antigen carrier. Lebens M, Holmgren J. Dev Biol Stand; 1994 Nov 01; 82():215-27. PubMed ID: 7958476 [Abstract] [Full Text] [Related]